Efficacy and Safety of Dupilumab in Older Patients (Aged 80 Years and Above) with Atopic Dermatitis: A Prospective Study
ConclusionsDupilumab treatment showed significant efficacy in improving atopic dermatitis symptoms in patients aged 80 years and above with a high level of safety. Larger long-term clinical trials are needed to validate these results and provide further evidence for the use of dupilumab in older patients with atopic dermatitis.
Source: Drugs and Aging - Category: Geriatrics Source Type: research
More News: Clinical Trials | Conjunctivitis | COVID-19 | Dermatitis | Dermatology | Eczema | Geriatrics | Pandemics | Skin | Study